Aplastic Anaemia (Bone Marrow Failure)
exp date isn't null, but text field is
Aplastic anaemia is defined as pancytopenia resulting from aplasia of the bone marrow. it can be inherited (Fanconi anaemia) or acquired (idiopathic, chemical or drug induced). It is one of haematological emergency.
Clinical presentation
Vary with severity but include;
- Anaemia, easy bruising/bleeding, recurrent infection;
- splenomegaly is not a feature.
Diagnostic Criteria
- Pancytopenia,
- Bone marrow hypocellularity of < 30% hematopoietic cells.
Investigations
- FBP, peripheral smear, reticulocyte count,
- Viral screening (HIV, Hepatitis B and C),
- Bone marrow aspiration and trephine biopsy.
Pharmacological Treatment Supportive treatment
B: blood transfusion (preferred irradiated, leucodepleted) when Hb<7g/dl
OR
S: platelet transfusion if bleeding or if platelet count is <10 X109/L. see dosage under
blood transfusion section 3.6
AND
Prophylactics antibiotics, hygiene, isolation of the patient, and use of masks to prevent neutropenic sepsis in patients with ANC of less than 0.5 X 109/L.
Note: Culture and sensitivity in patients with neutropenic sepsis. Refer to management of neutropenic sepsis under malignant diseases chapter.
Definitive treatment
Allogeneic haematopoietic stem cell transplantation is indicated in patients younger than 45yrs. Immunosuppressive Therapy
S: anti-thymocyte globulin (ATG) (IV) 40mg/kg/daily 4-10days
AND
S: cyclosporine (PO)2-10mg/kg/day 12hourly for 6-24months
AND
S: eltrombopag (PO): Children <5years; 2.5mg/kg 24hourly, 6-11years; 75mg 24hourly, >12 years; 150mg 24hourly for 6months
For patients who develop cyclosporine toxicity (nephrotoxicity, hypertension, gingival hypertrophy and hirsutism), the following drugs may be used although the response rate is low.
D: methylprednisolone (PO) 5–10mg/kg for 3–14days
OR
S: cyclophosphamide (IV) 45mg/kg /day for 4days
OR
S: danazol (PO) 5mg/kg/day for 6months
Note: Give supportive therapy and refer patients to higher health facility with adequate expertise and facilities. Monitor blood counts bi-monthly for outpatients, and as needed for admitted patients.